Cargando…
ATP2C2 as a novel immune-related marker that defines the tumor microenvironment in triple-negative breast cancer
BACKGROUND: Triple-negative breast cancer (TNBC) is an aggressive cancer that affects about 13/100,000 women yearly. Patients with TNBC are often resistant to endocrine and molecular targeted therapy, making clinical treatment challenging. Researches indicate that tumor microenvironment (TME) is rel...
Autores principales: | Zhao, Mingyuan, Zhang, Qilong, Song, Zichen, Lei, Huan, Li, Jing, Peng, Fang, Lin, Shuangyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425650/ https://www.ncbi.nlm.nih.gov/pubmed/37588742 http://dx.doi.org/10.21037/tcr-23-83 |
Ejemplares similares
-
ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer
por: Liu, Jiazhou, et al.
Publicado: (2021) -
Comparison of the tumor immune microenvironment of primary hormone receptor-negative HER2-positive and triple negative breast cancer
por: Vos, Hanne, et al.
Publicado: (2021) -
How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment
por: Saraiva, Diana P, et al.
Publicado: (2017) -
Integrating Genomic Information with Tumor-Immune Microenvironment in Triple-Negative Breast Cancer
por: Otohinoyi, David, et al.
Publicado: (2022) -
Composite Analysis of Immunological and Metabolic Markers Defines Novel Subtypes of Triple Negative Breast Cancer
por: Adams, Thomas A., et al.
Publicado: (2017)